Horvath Susan 4
4 · Panbela Therapeutics, Inc. · Filed Mar 29, 2023
Insider Transaction Report
Form 4
Horvath Susan
V.P. of Finance & CFO
Transactions
- Award
Stock Option (right to buy)
2023-03-27+34,369→ 34,369 totalExercise: $0.50Exp: 2033-03-27→ Common Stock (34,369 underlying)
Footnotes (1)
- [F1]The option fully vests on March 20, 2024, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.